Notice Number: NOT-NS-17-022
Key Dates
Release Date: April 24, 2017
Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
Purpose
The purpose of this Notice is to inform interested applicants that the expiration date for the Funding Opportunity Announcement (FOA) RFA NS-16-013 "Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems and/or Pharmacodynamic Markers to Facilitate the Discovery of Neurotherapeutics (R21/R33" will be extended by one receipt cycle. An additional non-AIDS new and resubmission application due date of February 20, 2018 and AIDS and AIDS-related application due date of May 7, 2018 have been added for this FOA. This FOA expires on May 8, 2018.
The Key Dates table is updated accordingly:
Key Dates
Application Due Date(s) |
February 18, 2016; June 21, 2016; October 18, 2016; February 21, 2017; June 21, 2017; October 18, 2017, February 20, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
AIDS Application Due Date(s) |
Standard AIDS dates (beginning on May 7, 2016) apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Scientific Merit Review |
June 2016; October 2016; February 2017; June 2017; October 2017; February 2018; June 2018 |
Advisory Council Review |
October 2016; January 2017; May 2017; October 2107; January 2018; May 2018; October 2018 |
Earliest Start Date |
November, 2016 |
Expiration Date |
May 8, 2018 |
Due Dates for E.O. 12372 |
Not Applicable |
All other aspects of the FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Mary Ann Pelleymounter, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: [email protected]